Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | purinergic receptor P2Y, G-protein coupled, 12 | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium vivax | circumsporozoite- and TRAP-related protein, putative | 0.0224 | 0.0149 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0224 | 0.0149 | 0.041 |
Schistosoma mansoni | dihydropyridine-sensitive l-type calcium channel | 0.5259 | 0.4341 | 1 |
Plasmodium vivax | von Willebrand factor A domain-related protein, putative | 0.0224 | 0.0149 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0224 | 0.0149 | 0.5 |
Brugia malayi | von Willebrand factor type A domain containing protein | 0.0224 | 0.0149 | 0.041 |
Loa Loa (eye worm) | hypothetical protein | 0.0224 | 0.0149 | 0.041 |
Echinococcus granulosus | voltage dependent calcium channel subunit | 0.5483 | 0.4528 | 0.4528 |
Schistosoma mansoni | serine/threonine protein kinase | 0.441 | 0.3634 | 0.8371 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0161 | 0.0096 | 0.0096 |
Plasmodium vivax | dynein-related AAA-type ATPase, putative | 0.0224 | 0.0149 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0224 | 0.0149 | 0.041 |
Brugia malayi | Zona pellucida-like domain containing protein | 0.0224 | 0.0149 | 0.041 |
Schistosoma mansoni | dihydropyridine-sensitive l-type calcium channel | 0.2651 | 0.217 | 0.4998 |
Schistosoma mansoni | serine-rich repeat protein | 0.2832 | 0.232 | 0.5345 |
Brugia malayi | von Willebrand factor type A domain containing protein | 0.0224 | 0.0149 | 0.041 |
Plasmodium vivax | thrombospondin-related anonymous protein | 0.0224 | 0.0149 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0224 | 0.0149 | 0.0343 |
Echinococcus multilocularis | voltage dependent calcium channel subunit | 1.2056 | 1 | 1 |
Plasmodium vivax | hypothetical protein, conserved | 0.0224 | 0.0149 | 0.5 |
Brugia malayi | hypothetical protein | 0.0224 | 0.0149 | 0.041 |
Brugia malayi | von Willebrand factor type A domain containing protein | 0.0224 | 0.0149 | 0.041 |
Loa Loa (eye worm) | hypothetical protein | 0.2427 | 0.1983 | 0.5458 |
Schistosoma mansoni | alpha-glucosidase | 0.0138 | 0.0078 | 0.0179 |
Loa Loa (eye worm) | hypothetical protein | 0.0224 | 0.0149 | 0.041 |
Schistosoma mansoni | alpha-glucosidase | 0.0138 | 0.0078 | 0.0179 |
Brugia malayi | map kinase activated protein kinase protein 2 | 0.441 | 0.3634 | 1 |
Loa Loa (eye worm) | CUTiclin-Like family member | 0.0224 | 0.0149 | 0.041 |
Onchocerca volvulus | 0.0224 | 0.0149 | 1 | |
Echinococcus multilocularis | microtubule associated protein 2 | 0.068 | 0.0529 | 0.0529 |
Loa Loa (eye worm) | hypothetical protein | 0.0224 | 0.0149 | 0.041 |
Treponema pallidum | hypothetical protein | 0.0224 | 0.0149 | 0.5 |
Onchocerca volvulus | 0.0224 | 0.0149 | 1 | |
Loa Loa (eye worm) | von Willebrand factor domain-containing protein | 0.0224 | 0.0149 | 0.041 |
Loa Loa (eye worm) | hypothetical protein | 0.0224 | 0.0149 | 0.041 |
Entamoeba histolytica | hypothetical protein, conserved | 0.0224 | 0.0149 | 0.5 |
Brugia malayi | von Willebrand factor type A domain containing protein | 0.0224 | 0.0149 | 0.041 |
Brugia malayi | von Willebrand factor type A domain containing protein | 0.0224 | 0.0149 | 0.041 |
Brugia malayi | von Willebrand factor type A domain containing protein | 0.0224 | 0.0149 | 0.041 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0161 | 0.0096 | 0.0096 |
Brugia malayi | von Willebrand factor type A domain containing protein | 0.0224 | 0.0149 | 0.041 |
Loa Loa (eye worm) | hypothetical protein | 0.0224 | 0.0149 | 0.041 |
Loa Loa (eye worm) | hypothetical protein | 0.0224 | 0.0149 | 0.041 |
Echinococcus granulosus | MAP kinase activated protein kinase 2 | 0.441 | 0.3634 | 0.3634 |
Loa Loa (eye worm) | hypothetical protein | 0.0224 | 0.0149 | 0.041 |
Loa Loa (eye worm) | camk/mapkapk/mapkapk protein kinase | 0.441 | 0.3634 | 1 |
Echinococcus granulosus | microtubule associated protein 2 | 0.068 | 0.0529 | 0.0529 |
Echinococcus granulosus | lysosomal alpha glucosidase | 0.0161 | 0.0096 | 0.0096 |
Brugia malayi | Glycosyl hydrolases family 31 protein | 0.0161 | 0.0096 | 0.0265 |
Onchocerca volvulus | 0.0224 | 0.0149 | 1 | |
Brugia malayi | Transmembrane cell adhesion receptor mua-3 precursor, putative | 0.0224 | 0.0149 | 0.041 |
Trichomonas vaginalis | ubiquitin-conjugating enzyme E2, putative | 0.0224 | 0.0149 | 0.5 |
Echinococcus multilocularis | voltage dependent calcium channel subunit | 0.5483 | 0.4528 | 0.4528 |
Onchocerca volvulus | 0.0224 | 0.0149 | 1 | |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0224 | 0.0149 | 0.041 |
Entamoeba histolytica | hypothetical protein, conserved | 0.0224 | 0.0149 | 0.5 |
Brugia malayi | Cache domain containing protein | 0.2427 | 0.1983 | 0.5458 |
Loa Loa (eye worm) | hypothetical protein | 0.0224 | 0.0149 | 0.041 |
Echinococcus multilocularis | collagen alpha 1(VII) chain | 0.0224 | 0.0149 | 0.0149 |
Plasmodium falciparum | thrombospondin-related anonymous protein | 0.0224 | 0.0149 | 0.5 |
Brugia malayi | von Willebrand factor type A domain containing protein | 0.0224 | 0.0149 | 0.041 |
Schistosoma mansoni | hypothetical protein | 0.0224 | 0.0149 | 0.0343 |
Echinococcus granulosus | collagen alpha 1VII chain | 0.0224 | 0.0149 | 0.0149 |
Loa Loa (eye worm) | hypothetical protein | 0.0224 | 0.0149 | 0.041 |
Loa Loa (eye worm) | hypothetical protein | 0.0224 | 0.0149 | 0.041 |
Toxoplasma gondii | microneme protein MIC2 | 0.0224 | 0.0149 | 0.5 |
Plasmodium falciparum | circumsporozoite- and TRAP-related protein | 0.0224 | 0.0149 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.2832 | 0.232 | 0.5345 |
Loa Loa (eye worm) | glycosyl hydrolase family 31 protein | 0.0161 | 0.0096 | 0.0265 |
Onchocerca volvulus | 0.0224 | 0.0149 | 1 | |
Loa Loa (eye worm) | von Willebrand factor type A domain-containing protein | 0.0224 | 0.0149 | 0.041 |
Brugia malayi | von Willebrand Factor | 0.0224 | 0.0149 | 0.041 |
Brugia malayi | Zona pellucida-like domain containing protein | 0.0224 | 0.0149 | 0.041 |
Plasmodium falciparum | von Willebrand factor A domain-related protein | 0.0224 | 0.0149 | 0.5 |
Echinococcus multilocularis | MAP kinase activated protein kinase 2 | 0.441 | 0.3634 | 0.3634 |
Schistosoma mansoni | microtubule-associated protein tau | 0.068 | 0.0529 | 0.1219 |
Loa Loa (eye worm) | hypothetical protein | 0.0224 | 0.0149 | 0.041 |
Onchocerca volvulus | 0.0224 | 0.0149 | 1 | |
Onchocerca volvulus | 0.0224 | 0.0149 | 1 | |
Loa Loa (eye worm) | CUTiclin family member | 0.0224 | 0.0149 | 0.041 |
Entamoeba histolytica | elongation factor-2 kinase, putative | 0.0224 | 0.0149 | 0.5 |
Toxoplasma gondii | von Willebrand factor type A domain-containing protein | 0.0224 | 0.0149 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0224 | 0.0149 | 0.041 |
Treponema pallidum | 76K protein | 0.0224 | 0.0149 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 43 nM | Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method | ChEMBL. | 25113932 |
Inhibition (ADMET) | Inhibition of CYP2D6 in human liver microsomes assessed as reduction in dextromethorphan-O demethylation | ChEMBL. | 25113932 | |
Inhibition (ADMET) | Inhibition of CYP3A4 in human liver microsomes assessed as reduction in testosterone 6beta-hydroxylation | ChEMBL. | 25113932 | |
Inhibition (ADMET) | Inhibition of CYP2C9 in human liver microsomes assessed as reduction in diclofenac 4'-hydroxylation | ChEMBL. | 25113932 | |
Inhibition (ADMET) | Inhibition of CYP3A4 in human liver microsomes assessed as reduction in midazolam 1'-hydroxylation | ChEMBL. | 25113932 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.